USANA Health Sciences (USNA) reported Q1 adjusted earnings late Tuesday of $0.73 per diluted share, down from $0.86 a year earlier.

A single analyst polled by FactSet expected $0.70.

Net sales for the quarter ended March 29 were $249.5 million, up from $227.8 million a year earlier.

A lone analyst surveyed by FactSet expected $243 million.

The company reiterated its full-year 2025 adjusted diluted EPS outlook of $2.35 to $3 and net sales guidance of $920 million to $1 billion. A single analyst polled by FactSet expects adjusted diluted EPS of $2.59 and net sales of $941.6 million.